Treatment as Prevention¨

Ending the HIV-AIDS Pandemic – Follow the Science

In July 1996, researchers, policymakers, and activists involved in the fight against HIV-AIDS met in Vancouver, Canada, for the 11th International Conference on AIDS. During that historic meeting, practitioners and patients heard evidence regarding a powerful weapon to stop the relentless onslaught of the human immunodeficiency virus (HIV): combination antiretroviral therapy (ART), with a protease […]

Ending the HIV-AIDS Pandemic – Follow the Science Read More »

One in five HIV-positive Canadians don’t know they’re HIV-positive

About 16,000 Canadians are living with HIV and don’t know it, according to statistics from Canada’s Public Health Agency (PHAC). That figure has prompted health experts to call for increased testing and more proactive treatment to reach people who haven’t been diagnosed and prevent them from spreading the illness to others. Dec. 1 marks World

One in five HIV-positive Canadians don’t know they’re HIV-positive Read More »

One in five HIV-positive Canadians don’t know they’re HIV-positive

About 16,000 Canadians are living with HIV and don’t know it, according to statistics from Canada’s Public Health Agency (PHAC). That figure has prompted health experts to call for increased testing and more proactive treatment to reach people who haven’t been diagnosed and prevent them from spreading the illness to others. Dec. 1 marks World

One in five HIV-positive Canadians don’t know they’re HIV-positive Read More »

Pre-exposure pill shows promise protecting against HIV infection but it’s pricey

The disclosure by HIV-positive actor Charlie Sheen’s ex-girlfriend that she took a pill to prevent her from getting the disease has focused attention on Truvada. The pill, which has been shown to reduce infection in HIV-negative partners of those with HIV by more than 90 per cent, is approved for that purpose in the U.S.

Pre-exposure pill shows promise protecting against HIV infection but it’s pricey Read More »

Testing, TasP, and PrEP; Canada could become world leader with new HIV strategy

It’s no secret that the last Canadian federal government, Stephen Harper’s Conservative party, did little in the fight again HIV. However, the new Justin Trudeau Liberal government has said they are committed to evidence-based decision making, and Vancouver’s MP, Dr Hedy Fry, is an enthusiastic supporter of Treatment as Prevention (“TasP”), and the wider 90-90-90

Testing, TasP, and PrEP; Canada could become world leader with new HIV strategy Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below